Induction Chemoimmunotherapy Combined With Chemoradiotherapy in Esophageal Cancer

Abroad (travel likely)RecruitingPHASE2

Conditions

Esophageal Cancer · Immunotherapy · Induction Therapy · Chemoradiotherapy · Surgery

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Anyang Cancer Hospital, Anyang, Henan, China

    Contact: Study coordinator (Xiaomin Wang, M.D.)
  • The First Affiliated Hospital of Xinxiang Medical University, Xinxiang, Henan, China

    Contact: Study coordinator (Xiaomei Liu, M.D.)
  • Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC), Beijing, China

    Contact: Study coordinator (Xin Wang, MD) · beryl_wx2000@163.com · +8601087787635
Study leads
  • Xin Wang

    Principal Investigator

    Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC)